Tianjin Ringpu Bio Tech (300119) — Working Capital to Net Assets Ratio
Tianjin Ringpu Bio Tech (300119) has a Working Capital to Net Assets ratio of 29.9% as of March 2026. Working capital of CN¥1.58 Billion (current assets of CN¥3.54 Billion minus current liabilities of CN¥1.96 Billion) is measured against net assets of CN¥5.27 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 300119 days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tianjin Ringpu Bio Tech Working Capital to Net Assets (2007–2025)
This chart shows how Tianjin Ringpu Bio Tech's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at 29.9%, reflecting working capital of CN¥1.58 Billion against net assets of CN¥5.27 Billion CNY. For the complete balance sheet picture, see how large is Tianjin Ringpu Bio Tech's balance sheet.
Annual Working Capital to Net Assets for Tianjin Ringpu Bio Tech (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tianjin Ringpu Bio Tech from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 300119 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 28.6% | CN¥1.48 Billion | CN¥5.18 Billion | CN¥3.37 Billion | CN¥1.89 Billion | ▲ +0.7 pp |
| 2024 | 27.9% | CN¥1.40 Billion | CN¥5.01 Billion | CN¥3.65 Billion | CN¥2.25 Billion | ▼ -12.0 pp |
| 2023 | 39.9% | CN¥1.92 Billion | CN¥4.80 Billion | CN¥3.26 Billion | CN¥1.34 Billion | ▲ +0.3 pp |
| 2022 | 39.6% | CN¥1.78 Billion | CN¥4.50 Billion | CN¥3.09 Billion | CN¥1.31 Billion | ▼ -5.2 pp |
| 2021 | 44.8% | CN¥1.94 Billion | CN¥4.32 Billion | CN¥3.06 Billion | CN¥1.12 Billion | ▲ +18.2 pp |
| 2020 | 26.6% | CN¥727.57 Million | CN¥2.74 Billion | CN¥1.60 Billion | CN¥877.23 Million | ▲ +6.0 pp |
| 2019 | 20.6% | CN¥486.17 Million | CN¥2.36 Billion | CN¥1.53 Billion | CN¥1.05 Billion | ▼ -10.2 pp |
| 2018 | 30.9% | CN¥695.90 Million | CN¥2.25 Billion | CN¥1.36 Billion | CN¥665.46 Million | ▲ +0.5 pp |
| 2017 | 30.4% | CN¥661.12 Million | CN¥2.18 Billion | CN¥1.32 Billion | CN¥657.30 Million | ▼ -0.7 pp |
| 2016 | 31.1% | CN¥655.37 Million | CN¥2.11 Billion | CN¥1.17 Billion | CN¥518.07 Million | ▲ +8.2 pp |
| 2015 | 22.9% | CN¥405.50 Million | CN¥1.77 Billion | CN¥900.89 Million | CN¥495.39 Million | ▼ -18.5 pp |
| 2014 | 41.4% | CN¥715.17 Million | CN¥1.73 Billion | CN¥902.33 Million | CN¥187.16 Million | ▼ -8.6 pp |
| 2013 | 50.0% | CN¥860.86 Million | CN¥1.72 Billion | CN¥1.08 Billion | CN¥215.22 Million | ▼ -12.6 pp |
| 2012 | 62.6% | CN¥993.27 Million | CN¥1.59 Billion | CN¥1.15 Billion | CN¥153.50 Million | ▼ -14.7 pp |
| 2011 | 77.3% | CN¥1.16 Billion | CN¥1.50 Billion | CN¥1.31 Billion | CN¥153.20 Million | ▼ -5.7 pp |
| 2010 | 83.0% | CN¥1.18 Billion | CN¥1.43 Billion | CN¥1.37 Billion | CN¥183.90 Million | ▲ +41.5 pp |
| 2009 | 41.4% | CN¥104.65 Million | CN¥252.48 Million | CN¥254.98 Million | CN¥150.33 Million | ▼ -13.1 pp |
| 2008 | 54.5% | CN¥136.26 Million | CN¥249.97 Million | CN¥208.64 Million | CN¥72.38 Million | ▼ -2.0 pp |
| 2007 | 56.5% | CN¥77.02 Million | CN¥136.21 Million | CN¥116.48 Million | CN¥39.46 Million | — |